Evaluation of Oral PF614 Relative to OxyContin (PF614-102)

Clinical trial NCT05043766 · COMPLETED

Trial details

NCT number: NCT05043766
Sponsor: Ensysce Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2021-09-08
Primary completion: 2022-03-21
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.